Episode Details
Back to Episodes
Episode 30: Challenges in Renal Disease Drug Development
Published 7 years ago
Description
Pharm Exec editors interview Anna Sundgren, the renal disease strategy leader, Global Medicines Development at AstraZeneca, about the current CVRM landscape, challenges to renal drug development, and new therapeutics for chronic kidney disease.
This podcast was brought to you by QxMD.
This podcast was brought to you by QxMD.